Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.785131
Title: Defining end-user acceptability attributes of orodispersible films for patient centricity
Author: Scarpa, Mariagiovanna
ISNI:       0000 0004 7970 6734
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Poor acceptability has been associated with low compliance, particularly in special patient populations. Patient acceptability assessment of individual dosage form attributes offers the advantage of providing information to the manufacturer on the strategy to adopt for optimising the dosage form design at an early drug product development stage. The development of in vitro methods capable of predicting attribute acceptability based on the quantitative measurement of relevant formulation variables could provide the manufacturer with a decision-supporting toolkit to guide the development of acceptable drug products. However, there is a great need of defining standard methodologies for the assessment of patient acceptability as the current knowledge is fragmented in this field. The orodispersible film (ODF) platform is considered patient-centric, however its attributes have rarely been assessed for acceptability on an individual basis. The aims of this study are to identify key acceptability attributes of the ODF platform by in vivo methods, and to develop and optimise in vitro methods to predict acceptability. ODF placebo samples differing in specific formulation variables were prepared and the corresponding acceptability attributes were assessed by human panel. Only some attributes differed among samples in the human panel study, and therefore were identified as key acceptability attributes. A series of in vitro methods for the prediction of ODF attribute acceptability were developed and optimised, and the same sample set was tested. In vitro methods were considered predictive if the measured variable directly or indirectly correlated with the in vivo acceptability assessment. Application of the proposed strategy in the acceptability assessment of oral dosage forms was shown, and key acceptability attributes (stickiness, disintegration time) and in vitro predictive methods (dynamic mechanical analysis, mechanical oral cavity model) were identified for the ODF platform.
Supervisor: Orlu, M. Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.785131  DOI: Not available
Share: